Generic Rozerem is currently unavailable because the medication's first patent does not expire until 2017. Unless lawsuits or other patents for the sleep medicine arise to extend the exclusivity period, several drug companies are expected to begin manufacturing generic Rozerem after the patent expires.
Rozerem is manufactured by Takeda Pharmaceuticals. It is currently under the protection of a patent that prevents any generic Rozerem from being manufactured in the United States. Yet, if you search the Internet for "generic Rozerem," you may find a number of companies selling it. The fact is, these medicines are fake, substandard, and potentially dangerous. There may be generic Rozerem available from another country, but there is really no way of knowing whether these products are genuine Rozerem. You should not buy any generic Rozerem until there is an approved version available.
The first patent for Rozerem currently expires in 2017. This is the earliest possible date that a generic version of Rozerem could become available. However, there are other circumstances that could come up to extend the exclusivity period of Rozerem beyond 2017. This could include such things as other patents for specific Rozerem uses or lawsuits. Once Rozerem goes off patent, there may be several companies that will begin manufacturing a generic Rozerem drug.
The answer is no. Ramelteon is the active ingredient in Rozerem but is not a generic version of Rozerem. Oftentimes, the active ingredient of any drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off patent, and then another company (besides the original manufacturer) would make the product.